Spotting while on HRT

Hormone replacement therapy can alter the lining of the womb, particularly after treatment begins, a dose changes, or doses are missed. The type of HRT matters: sequential regimens may include a planned bleed, while continuous regimens are intended to avoid regular bleeding after adjustment. Spotting can also come from vaginal dryness or irritation, infection such as Chlamydia, Cervical Dysplasia, Endometrial Polyps, or Uterine Fibroids. Bleeding after menopause can occasionally be a presentation of Womb Cancer or Cervical Cancer, so it should not be dismissed as a medication effect.

Keep a record of your HRT names, doses, missed doses, bleeding dates, and any pain or discharge. A clinician may review how you take treatment and consider an examination, pregnancy test where relevant, infection testing, or an ultrasound.

Continue HRT as prescribed until the prescriber advises otherwise, and do not change the dose yourself. Contact the prescribing clinician if spotting is new, heavier, lasts beyond the expected adjustment period, returns after settling, or happens after a long interval without bleeding. Mention vaginal symptoms, missed tablets, recent procedures, and medicines that affect bleeding. Use a liner if helpful and keep the record for your appointment.

Seek urgent help if bleeding is heavy or rapidly worsening, or if it comes with faintness, severe pelvic pain, fever, or marked weakness. Arrange prompt assessment for any bleeding after menopause, especially when it recurs or follows sex. The aim is to identify whether HRT needs adjusting and to exclude infection or a cervical or womb problem.

Ask whether your bleeding pattern fits your HRT schedule, whether a missed dose could explain it, and what examination or tests are appropriate. Ask when bleeding should settle, what to do if it returns, and whether your cervical screening is current.